These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 392546)

  • 1. Protection from mutagenic effects of antischistosomal and other drugs.
    Bueding E; Batzinger RP; Cha YN; Talalay P; Molineaux CJ
    Pharmacol Rev; 1978 Dec; 30(4):547-54. PubMed ID: 392546
    [No Abstract]   [Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.
    Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H
    Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides.
    Frohberg H; Schulze Schencking M
    Arzneimittelforschung; 1981; 31(3a):555-65. PubMed ID: 7195246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of mutagenic and other toxic properties from schistosomicides.
    Bueding E
    J Toxicol Environ Health; 1975 Nov; 1(2):329-34. PubMed ID: 1206775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivo.
    Molineaux CJ; Batzinger RP; Schmidt W; Bueding E
    Teratog Carcinog Mutagen; 1980; 1(2):129-39. PubMed ID: 6119805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hycanthone analogs: dissociation of mutagenic effects from antischistosomal effects.
    Hulbert PB; Bueding E; Hartman PE
    Science; 1974 Nov; 186(4164):647-8. PubMed ID: 4413726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of carcinogens and mutagens on nucleic acids. V. On the interaction of DNA with sarcolysin].
    Kushner VP; Khodosova IA
    Tsitologiia; 1968 Oct; 10(10):1313-8. PubMed ID: 5733949
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology and biochemistry of N-oxides.
    Bickel MH
    Pharmacol Rev; 1969 Dec; 21(4):325-55. PubMed ID: 4902323
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenicity of derivatives of the oncogenic purine N-oxides.
    McCuen RW; Stöhrer G; Sirotnak FM
    Cancer Res; 1974 Feb; 34(2):378-84. PubMed ID: 4204232
    [No Abstract]   [Full Text] [Related]  

  • 10. [The cis-isomer of antischistosomal drug furapromide].
    Xu ML; Ye DY; Zhang YL; Lei XH
    Yao Xue Xue Bao; 1982 Dec; 17(12):905-8. PubMed ID: 7183122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxicity, carcinogenic, mutagenic, teratogenic action of dichlorvos].
    Lafontaine A; Aerts J; Jacques P
    Arch Belg Med Soc; 1981 Mar; 39(3):159-74. PubMed ID: 7030204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the biological effects of quinoxaline-1,4-dioxide].
    Novácek L; Seménková L; Vavrínová D; Soska J; Sevcík B
    Cesk Farm; 1984 Jun; 33(5):196-200. PubMed ID: 6388863
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mutagenic activity of nitrothiazole compounds].
    Hof H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):64-70. PubMed ID: 3901605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical carcinogenesis: mechanisms and approaches to its control.
    Miller JA; Miller EC
    J Natl Cancer Inst; 1971 Sep; 47(3):V-XIV. PubMed ID: 5157587
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of some mutagenic virogens and carcinogens on deoxyribonucleic acid.
    Yamafuji K; Uchida Y
    Enzymologia; 1968 Sep; 35(3):131-8. PubMed ID: 4301138
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mutagenicity and teratogenicity of furapyrimidone].
    Ni YC; Shao BR; Zhan CQ; Xu YQ; Ha SH; Jiao PY
    Zhongguo Yao Li Xue Bao; 1983 Sep; 4(3):201-5. PubMed ID: 6228123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of carcinogens and mutagens on nucleic acids. IV. On the influence of the ionic strength of the solution on the thermal denaturation characteristics of DNA treated with nitrous acid and hydroxylamine].
    Kushner VP; Khodosova IA
    Tsitologiia; 1967 Aug; 9(8):967-73. PubMed ID: 6081363
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of the acute toxicity of mutagenic and carcinogenic chemicals in the mouse by prefeeding with antioxidants.
    Cumming RB; Walton MF
    Food Cosmet Toxicol; 1973 Aug; 11(4):547-53. PubMed ID: 4357196
    [No Abstract]   [Full Text] [Related]  

  • 19. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk.
    Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM
    Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of rapid test systems for detecting the carcinogenic and mutagenic activity of chemical compounds].
    Zakharov IA; Kasinova GV; Koval'tsova SV; Marfin SV
    Izv Akad Nauk SSSR Biol; 1984; (5):729-45. PubMed ID: 6501695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.